FARRINGTON DEBORAH A
Known title: DirectorCIK: 0001260341
Associated companies
Transaction History
| VYX | ▲ Buy | Grant | 10,761 | $225K | 5/2/2023 | View on chart |
| VYX | ▲ Buy | Grant | 6,479 | $225K | 5/2/2022 | View on chart |
| VYX | ▲ Buy | Grant | 10,761 | $225K | 5/2/2023 | View on chart |
| VYX | ▲ Buy | Grant | 6,479 | $225K | 5/2/2022 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Goldman Sachs cuts NCR Voyix price target to $8
Goldman Sachs maintained a Neutral rating on NCR Voyix but lowered its price target to $8. This action follows the company's recent Q2 2026 earnings call. The new target is below the current average analyst estimate of $12.96, reflecting a cautious outlook from the firm.
Goldman Sachs cuts NCR Voyix price target to $8. Goldman Sachs maintained a Neutral rating on NCR Voyix but lowered its price target to $8. This action follows the company's recent Q2 2026 earnings call. The new target is below the current average analyst estimate of $12.96, reflecting a cautious outlook from the firm.